HomeScreenerMNKDProfile
F
35/100

MannKind Corporation

MNKDEndocrinology
📋
Analyst Summary
✓ VERIFIED2026-04-11

MannKind Corporation (MNKD) is the lead sponsor of 3 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 2 Phase 1[2].

MNKD has 6 Form 4 insider filings recorded at the SEC in the past 30 days[4].

Sources

  1. ClinicalTrials.gov (2026-04-11)
  2. ClinicalTrials.gov (2026-04-11)
  3. ClinicalTrials.gov (2026-04-11)
  4. SEC EDGAR · 0000899460 (2026-04-11)
🔬
Clinical Trials
3
NCT06532942Healthy Volunteers
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07224321Type 1 Diabetes Mellitus
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07344558Idiopathic Pulmonary Fibrosis (IPF)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
6 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Data Provenance
cik1 verified
clinical trial3 verified
insider buy1 verified
trial count3 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR